Trends in Genotypic HIV-1 Antiretroviral Resistance between 2006 and 2012 in South African Patients Receiving First- and Second-Line Antiretroviral Treatment Regimens

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Van Zyl, Gert U ^a,b   Liu, Tommy F ^c   Claassen, Mathilda ^a,b   Engelbrecht, Susan ^a,b   de Oliveira, Tulio ^d   Preiser, Wolfgang ^a,b   Wood, Natasha T ^e   Travers, Simon ^e   Shafer, Robert W ^c  

^a NATIONAL HEALTH LABORATORY SERVICE   (South Africa)

^b UNIVERSITY OF STELLENBOSCH   (South Africa)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF KWAZULU NATAL   (South Africa)

^e UNIVERSITY OF THE WESTERN CAPE   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; ANTIRETROVIRUS AGENT; DARUNAVIR; DIDANOSINE; EFAVIRENZ; LAMIVUDINE; LOPINAVIR; LOPINAVIR PLUS RITONAVIR; NEVIRAPINE; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; TENOFOVIR; TENOFOVIR DISOPROXIL; ZIDOVUDINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; HUMAN IMMUNODEFICIENCY VIRUS PROTEINASE;

ADOLESCENT; ADULT; ANTIVIRAL RESISTANCE; ANTIVIRAL THERAPY; ARTICLE; BLOOD SAMPLING; CHILD; CONTROLLED STUDY; CROSS RESISTANCE; DRUG TREATMENT FAILURE; FEMALE; GENE MUTATION; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INFANT; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRESCHOOL CHILD; SCHOOL CHILD; SOUTH AFRICA; DRUG EFFECTS; ENZYMOLOGY; GENETICS; HIV INFECTIONS; MIDDLE AGED; MUTATION; PHYSIOLOGY; TREATMENT FAILURE; YOUNG ADULT;

HUMAN IMMUNODEFICIENCY VIRUS 1;

ADOLESCENT; ADULT; ANTI-HIV AGENTS; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, VIRAL; FEMALE; GENOTYPE; HIV INFECTIONS; HIV PROTEASE; HIV REVERSE TRANSCRIPTASE; HIV-1; HUMANS; INFANT; MALE; MIDDLE AGED; MUTATION; REVERSE TRANSCRIPTASE INHIBITORS; SOUTH AFRICA; TREATMENT FAILURE; YOUNG ADULT;

EID: 84879487227     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0067188     Document Type: Article

References (18)

1. (2010) National Department of Health, South Africa. Clinical Guidelines for the Management of HIV&AIDS in Adults and Adolescents, 2010. Available: http://hivfshealth.org/document/2010/08/19/clinical-guidelines-for-the-management-of-hiv-aids-in-adults-and-adolescents. Accessed 2012 Nov 19.
2. (2010) National Department of Health, South Africa. Guidelines for the Management of HIV in children, 2nd Edition 2010. Available: http://hivfshealth.org/document/2010/08/19/guidelines-for-the-management-of-hiv-in-children-2nd-edition-2010. Accessed 2012 Nov 19.
3. Sunpath H, Hampton J, Gordon M, Maharaj R, Moosa Y, et al. (2012) High Rate of K65R for ART-naïve Patients with Subtype C HIV Infection Failing a Tenofovir-containing First-line Regimen: South Africa. 19th Conference on Retroviruses and Opportunistic Infections, 5-8 March 2012. Seattle, USA.
4. (2004) Department of Health, South Africa. National Antiretroviral Treatment Guidelines, South Africa. Available: http://www.kznhealth.gov.za/arv/arv5.pdf. Accessed 2012 Nov 19.
5. van Zyl GU, Claassen M, Engelbrecht S, Laten JD, Cotton MF, et al. (2008) Zidovudine with nevirapine for the prevention of HIV mother-to-child transmission reduces nevirapine resistance in mothers from the Western Cape, South Africa. J Med Virol 80: 942-946.
6. Alcantara LC, Cassol S, Libin P, Deforche K, Pybus OG, et al. (2009) A standardized framework for accurate, high-throughput genotyping of recombinant and non-recombinant viral sequences. Nucleic Acids Res 37: W634-642.
7. Rey D, Hoen B, Chavanet P, Schmitt MP, Hoizey G, et al. (2009) High rate of early virological failure with the once-daily tenofovir/lamivudine/nevirapine combination in naive HIV-1-infected patients. J Antimicrob Chemother 63: 380-388.
8. Tang MW, Kanki PJ, Shafer RW, (2012) A review of the virological efficacy of the 4 world health organization-recommended tenofovir-containing regimens for initial HIV therapy. Clin Infect Dis 54: 862-875.
9. Wallis CL, Mellors JW, Venter WD, Sanne I, Stevens W, (2010) Varied patterns of HIV-1 drug resistance on failing first-line antiretroviral therapy in South Africa. J Acquir Immune Defic Syndr 53: 480-484.
10. Morris L, Pillay C, Chezzi C, Lupondwana P, Ntsala M, et al. (2003) Low frequency of the V106M mutation among HIV-1 subtype C-infected pregnant women exposed to nevirapine. AIDS 17: 1698-1700.
11. Pillay V, Pillay C, Kantor R, Venter F, Levin L, et al. (2008) HIV type 1 subtype C drug resistance among pediatric and adult South African patients failing antiretroviral therapy. AIDS Res Hum Retroviruses 24: 1449-1454.
12. Johnson VA, Brun-Vezinet F, Clotet B, Conway B, D'Aquila RT, et al. (2003) Drug resistance mutations in HIV-1. Top HIV Med 11: 215-221.
13. Hassani Espili N, Bergroth T, Pavlova A, Shao X-W, McKenna P, et al. (2004) Effects of mutations associated with suppression of zidovudine resistance in HIV-1 reverse transcriptase on removal of tenofovir from blocked primer/template. Antivir Ther 9: S28.
14. Parkin NT, Chappey C, Petropoulos CJ, Hellmann N (2003) HIV-1 reverse transcriptase mutations that suppress zidovudine resistance also increase in vitro susceptibility to tenofovir, but not stavudine. XII International HIV Drug Resistance Workshop. Los Cabos, Mexico.
15. Trivedi V, Von Lindern J, Montes-Walters M, Rojo DR, Shell EJ, et al. (2008) Impact of human immunodeficiency virus type 1 reverse transcriptase inhibitor drug resistance mutation interactions on phenotypic susceptibility. AIDS Res Hum Retroviruses 24: 1291-1300.
16. Barber TJ, Harrison L, Asboe D, Williams I, Kirk S, et al. (2012) Frequency and patterns of protease gene resistance mutations in HIV-infected patients treated with lopinavir/ritonavir as their first protease inhibitor. J Antimicrob Chemother 67: 995-1000.
17. Wallis CL, Mellors JW, Venter WD, Sanne I, Stevens W, (2011) Protease Inhibitor Resistance Is Uncommon in HIV-1 Subtype C Infected Patients on Failing Second-Line Lopinavir/r-Containing Antiretroviral Therapy in South Africa. AIDS Res Treat 2011: 769627.
18. de Oliveira T, Shafer RW, Seebregts C, (2010) Public database for HIV drug resistance in southern Africa. Nature 464: 673.